CDC ends universal newborn hepatitis B vaccine recommendations
The US Centers for Disease and Prevention (CDC) no longer recommends that all US newborns receive the hepatitis B vaccine, …
Post
-
-
GSK obtains FDA approval for Exdensur in severe asthma
GSK has secured approval from the US Food and Drug Administration (FDA) for its severe asthma add-on maintenance therapy, Exdensur …
-
Harbour BioMed and BMS sign multi-specific antibody collab
Harbour BioMed and Bristol Myers Squibb (BMS) have signed a multi-year, worldwide strategic partnership and licence agreement focused on multi-specific …
-
Precision medicine approaches needed in oncology to match evolving SoC
As the standard of care (SoC) for new drugs in oncology continues to improve, trials need to be designed with …
-
INCOG reveals $200m injectable drug expansion in Indiana
Contract development and manufacturing organisation (CDMO) INCOG BioPharma Services has announced injectable drug manufacturing expansion at its Fishers facility in …
-
Pharmaceutical Technology Excellence Awards 2025: Cellular Origins
Cellular Origins, a company enabling the manufacture of cell therapies at scale through a flexible, mobile robotic automation platform, has …
-
States consider payment limits to curb prescription drug prices with PDABs
Four weeks into her pregnancy, Jessica Intermill sensed something was wrong when the pain in her fingers wouldn’t subside. What …
-
Pharmaceutical Technology Excellence Awards 2025: BostonGene
BostonGene earned four distinctions in the 2025 Pharmaceutical Technology Excellence Awards, recognizing its leadership in applying artificial intelligence (AI) and …
-
Sanofi signs pair of billion-dollar biotech deals to bolster pipeline
Following the disappointment of a multiple sclerosis (MS) trial readout this week, Sanofi has signed a pair of deals in …
-
Pfizer trims 2026 profit forecast amid Covid headwinds and patent cliff pressures
Pfizer has set its FY2026 profit forecast below analyst estimates, blaming projected losses on waning Covid vaccine sales and the …
-
Pharma M&A deal value up 31% YoY in 2025YTD amid return of mega-deals
Mergers and acquisitions (M&As) in the pharmaceutical industry already witnessed a 31% increase in total deal value from $137.1 billion …
-
The hidden crisis in regenerative medicine
Dr Tommy Rhee, CEO of RheeGen, outlines how FDA crackdowns have revealed dangerous and unethical tissue sourcing practices: Two decades ago, …
-
Transforming medical imaging in Scotland with AI
The global shortage of radiologists is having a serious impact on diagnostics and delaying medical treatments, but AI tools for …
-
LEO Pharma applies to EMA to expand Anzupgo use to adolescents
LEO Pharma has submitted an application to the European Medicines Agency (EMA) seeking to expand the label for Anzupgo (delgocitinib) …
-
High-value oncology deals drive China’s drug licensing boom
As 2025 draws to a close, China’s meteoric rise in the innovative medicines segment has undeniably captured the attention of …
